Knilonat 200mg Capsule (Nilotinib)

Knilonat 200mg Capsule is used in the treatment and management of specific leukemia-related conditions.

• Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
• Chronic phase chronic myeloid leukemia
• Accelerated phase chronic myeloid leukemia
• CML resistant to previous therapy
• CML intolerant to previous treatment
• Targeted leukemia therapy
• Blood cancer management under oncology supervision

Doctors may prescribe Knilonat 200mg Capsule as part of a long-term targeted cancer treatment plan.

Knilonat 200mg Capsule contains Nilotinib, a tyrosine kinase inhibitor (TKI) that targets abnormal BCR-ABL proteins associated with chronic myeloid leukemia.

Nilotinib works by:

• Blocking abnormal cancer signaling pathways
• Slowing leukemia cell growth
• Reducing multiplication of cancer cells
• Helping control disease progression
• Targeting specific leukemia-related proteins

By selectively targeting cancer cells, Nilotinib helps improve disease control in patients with Philadelphia chromosome-positive leukemia.

Knilonat 200mg Capsule offers several important benefits in chronic myeloid leukemia management.

• Targets leukemia cells specifically
• Helps slow disease progression
• Supports long-term leukemia management
• Useful in resistant or intolerant CML cases
• May improve hematological response
• Supports targeted cancer therapy
• May improve disease control outcomes
• Supports oncology treatment protocols

Targeted therapy medicines help improve precision treatment approaches in modern cancer care.

Chronic myeloid leukemia (CML) is a type of blood cancer that affects white blood cells and bone marrow. It is commonly associated with the Philadelphia chromosome abnormality.

Common symptoms of CML may include:

• Fatigue
• Weakness
• Weight loss
• Night sweats
• Fever
• Enlarged spleen
• Bone pain
• Frequent infections

Knilonat 200mg Capsule helps target the abnormal proteins responsible for leukemia cell growth in Ph+ CML patients.

The dosage of Knilonat 200mg Capsule depends on:

• Type and phase of leukemia
• Patient response to treatment
• Previous treatment history
• Blood test results
• Doctor’s recommendation

Important administration instructions:

• Take exactly as prescribed
• Swallow capsules whole with water
• Usually taken on an empty stomach
• Do not crush or open capsules
• Regular blood monitoring is required
• Follow oncology specialist guidance carefully

Do not alter dosage or discontinue therapy without medical advice.

Like all anti-cancer medicines, Knilonat 200mg Capsule may cause side effects in some patients.

Common Side Effects

• Nausea
• Fatigue
• Headache
• Rash
• Constipation
• Muscle pain
• Joint pain
• Itching
• Weakness

Serious Side Effects

Seek immediate medical attention if you experience:

• Irregular heartbeat
• Chest pain
• Severe dizziness
• Breathing difficulty
• Severe infections
• Liver-related symptoms
• Severe allergic reactions

Regular laboratory monitoring is important during treatment.

Before using Knilonat 200mg Capsule, inform your doctor if you have:

• Heart disease
• Liver disease
• Electrolyte imbalance
• History of pancreatitis
• Bleeding disorders
• Kidney disease
• Pregnancy or breastfeeding
• Other chronic illnesses

Regular ECG, blood tests, liver function tests, and electrolyte monitoring may be required during treatment.

Avoid grapefruit products unless approved by your healthcare provider.

Knilonat 200mg Capsule may interact with several medicines.

• Antifungal medicines
• Antibiotics
• Heart rhythm medications
• Blood thinners
• Antacid medicines
• Other anti-cancer therapies
• Liver enzyme-affecting medicines

Always inform your oncologist about all medicines, supplements, and herbal products you are using.

Pregnancy: Knilonat 200mg Capsule may harm the unborn baby and should only be used if specifically advised by a specialist.

Breastfeeding: Breastfeeding is generally not recommended during treatment with Nilotinib.

Discuss appropriate contraception and reproductive safety measures with your healthcare provider.

• Store in a cool and dry place
• Protect from moisture and direct sunlight
• Keep away from heat
• Keep out of reach of children
• Store according to package instructions
• Check expiry date before use

What is Knilonat 200mg Capsule used for?

Knilonat 200mg Capsule is used for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).

What does Knilonat 200mg Capsule contain?

It contains Nilotinib 200mg.

How does Knilonat 200mg Capsule work?

It works by blocking abnormal proteins that promote leukemia cell growth and multiplication.

Is Knilonat 200mg Capsule a chemotherapy medicine?

Knilonat 200mg Capsule is a targeted anti-cancer therapy classified as a tyrosine kinase inhibitor.

Can Knilonat 200mg Capsule treat resistant CML?

Yes, it may be prescribed in patients who are resistant or intolerant to previous therapies.

Is prescription required?

Yes, Knilonat 200mg Capsule should only be used under oncology specialist supervision with a valid prescription.

You can buy Knilonat 200mg Capsule (Nilotinib) online from a licensed oncology pharmacy with a valid prescription. Always purchase anti-cancer medicines from trusted suppliers to ensure product authenticity, quality, and proper storage conditions.

Before purchasing online:

• Verify prescription requirements
• Check dosage strength
• Review storage instructions
• Purchase only from licensed pharmacies
• Consult your oncologist before use